Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

One Acetaminophen Headache Remains Untreated: Acronyms On Pharmacy Containers

Executive Summary

FDA hopes to curtail acetaminophen overdosing by requiring manufacturers to restrict the amount of the drug in combination Rx products. But another potential cause of overdosing remains intact: the use of acronyms on pharmacy labels.

You may also be interested in...



Pressure Builds For Revamped Acetaminophen Warnings In Rx Dispensing Materials

A white paper by the National Council for Prescription Drug Programs calls on industry to harmonize Rx labeling with existing labeling for OTC medicines.

Pressure Builds For Revamped Acetaminophen Warnings In Rx Dispensing Materials

A white paper by the National Council for Prescription Drug Programs calls on industry to harmonize Rx labeling with existing labeling for OTC medicines.

FDA's Chicken Or Egg Question For Pharmacy Leaflets: Should Benefit Or Risk Come First?

FDA will look at which should come first – benefits or risks – when it studies patients' response to three one-page prototypes of patient medication information.

Related Content

Topics

UsernamePublicRestriction

Register

PS053062

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel